Position in CGON
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$34,420,954
+$8,805,428 QoQ
Shares Held
484,461
+28.0% QoQ
Ownership
0.547%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#38
of 226 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGON Over Time
Shares Held
Position Value (USD)
Derivatives in CGON
reported options exposure · as of Jun 30, 2026CallValue
$126,412,160
CallShares
1,779,200
PutValue
$84,918,960
PutShares
1,195,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. CGON ranks #1 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
This page
|
484,461 | $34,420,954 | |
| 2 | INSM |
INSMED Inc
|
236,000 | $25,162,320 | |
| 3 | ERAS |
Erasca, Inc.
|
1,041,225 | $19,075,242 | |
| 4 | CELC |
Celcuity Inc.
|
170,000 | $17,785,400 | |
| 5 | DSGN |
Design Therapeutics, Inc.
|
1,118,098 | $16,178,878 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
413,087 | $11,145,087 | |
| 7 | REPL |
Replimune Group, Inc.
|
783,873 | $8,677,474 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
120,700 | $7,596,858 |
All Filings in CGON
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $126,412,160 | 1,779,200 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $34,420,954 | 484,461 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $84,918,960 | 1,195,200 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $78,508,800 | 1,160,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $82,596,672 | 1,220,400 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $25,615,526 | 378,480 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $25,011,648 | 602,400 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $16,608,000 | 400,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $12,740,245 | 306,846 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,081,420 | 76,500 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $14,375,400 | 552,900 | Call | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||